作者：
Esmee P,Hoefsmit [1]
;
Elisa A,Rozeman [2]
;
Trieu My,Van [1]
;
Petros,Dimitriadis [1]
;
Oscar,Krijgsman [1]
;
Jordan W,Conway [3]
;
Ines,Pires da Silva [3]
;
Jacqueline E,van der Wal [4]
;
Steven L C,Ketelaars [1]
;
Kaspar,Bresser [1]
;
Annegien,Broeks [5]
;
Ron M,Kerkhoven [6]
;
Jason W,Reeves [7]
;
Sarah,Warren [7]
;
Pia,Kvistborg [1]
;
Richard A,Scolyer [3]
;
Ellen W,Kapiteijn [8]
;
Daniel S,Peeper [9]
;
Georgina V,Long [10]
;
Ton N M,Schumacher [1]
;
Christian U,Blank [11]
作者单位：
Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[1]
Medical Oncology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[2]
Melanoma Institute Australia, North Sydney, New South Wales, Australia.
[3]
Department of Pathology, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[4]
Core Facility and Biobanking, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[5]
NKI Genomics Core Facility, Netherlands Cancer Institute, Amsterdam, The Netherlands.
[6]
NanoString Technologies Inc, Seattle, Washington, USA.
[7]
The University of Sydney Faculty of Medicine and Health, Sydney, New South Wales, Australia.
[8]
Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital and New South Wales Health Pathology, Sydney, New South Wales, Australia.
[9]
Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands.
[10]
Oncode Institute, Utrecht, The Netherlands.
[11]
Royal North Shore Hospital, Melanoma Institute Australia, and The University of Sydney, Wollstonecraft, New South Wales, Australia.
[12]
Molecular Oncology & Immunology, Netherlands Cancer Institute, Amsterdam, The Netherlands c.blank@nki.nl.
[13]
DOI
10.1136/jitc-2020-001501
PMID
33262254
发布时间
2023-12-13
换一批
换一批
